Ignite Creation Date:
2024-05-06 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05751733
Status:
RECRUITING
Last Update Posted:
2023-03-02
First Post:
2023-02-08
Brief Title:
Apatinib Mesylate Versus Standard Second-line TKI in the Treatment of Advanced GIST
Sponsor:
Xiangya Hospital of Central South University
Organization:
Xiangya Hospital of Central South University